Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...
IRSF investment positions organization at the forefront of early-stage Rett research as genomic medicine reshapes rare ...
The FDA released a much-anticipated draft guidance on how makers of rare disease genetic medicines can leverage a platform ...
A new study has shed light on why patients with certain rare immune disorders develop severe, food-triggered allergic reactions while others with similar diagnoses do not. The findings, published in ...
At an event on Monday, the agency officially unveiled long-awaited draft guidance meant to help speed the development of bespoke treatments for extremely rare diseases.
Today, the FDA issued draft guidance outlining a new regulatory pathway intended to help sponsors gain approval for highly ...
According to an FDA press release, the draft guidance "focuses on therapies that target a specific genetic, cellular, or molecular abnormality and are designed to correct or modify the underlying ...
When a plant's immune system is triggered, its growth is stunted. Colorado State University researchers have discovered how to turn on a hormone that allows plants to keep growing as they defend ...
Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic "base pairs" to a new level of precision, opening the door to safer, more ...
Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic ...
The FDA expects a flood of applications for a new "plausible mechanism pathway" for approval of bespoke gene-editing treatments.
The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results